To investigate the impact of SK1 silencing in melanoma cells on the anti-tumor immune response, we analyzed the lymphocyte infiltration of tumors in mice injected either with shCtrl or shSK1(1) Yumm cells at day 11. The gene discussed is SPHK1; the disease is neoplasm.